Cutaneous squamous cell carcinoma in human immunodeficiency virus- infected patients: A study of epidemiologic risk factors, human papillomavirus, and p53 expression

Archives of Dermatology

Volumn 133, Issue 5, 1997, Pages 577-583

  Maurer, Toby A ^a,d   Christian, Kirsten Vin ^a   Kerschmann, Russell L ^a   Berzin, Bella ^b   Palefsky, Joel M ^a   Payne, Deborah ^c   Tyring, Stephen K ^c   Berger, Timothy G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KAISER FOUNDATION HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d SAN FRANCISCO GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; ARTICLE; BASAL CELL CARCINOMA; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; VERRUCA VULGARIS; WART VIRUS;

EID: 0031010684     PISSN: 0003987X     EISSN: None     Source Type: Journal    
DOI: 10.1001/archderm.133.5.577     Document Type: Article

References (55)

1. Smith KJ, Skelton HG, Yeager J, et al. Cutaneous findings in HIV-1-positive patients: a 42-month prospective study. J Am Acad Dermatol. 1994;31:746-754.
2. Smith SE, Davis IC, Leshin B, Fleischer AB Jr, White WL, Feldman SR. Absence of human papillomavirus in squamous cell carcinomas of nongenital skin from immunocompromised renal transplant patients. Arch Dermatol 1993;129:1585-1588.
3. Lobo DV, Chu P, Grekin RC, Berger TG. Nonmelanoma skin cancers and infection with the human immunodeficiency virus. Arch Dermatol. 1992;128:623-627.
4. Payne D, Newman C, Tyring S. Human papillomavirus DNA in nonanogenital keratoacanthoma and squamous cell carcinoma of patients with HIV infection. J Am Acad Dermatol. 1995;33:1047-1049.
5. Chang F. Role of papillomaviruses. J Clin Pathol. 1990;43:269-276.
6. Woodworth CD, Waggoner S, Barnes W, Stoler MH, DiPaolo JA. Human cervical and foreskin epithelial cells immortalized by human papillomavirus DNAs exhibit dysplastic differentiation in vivo. Cancer Res. 1990;50:3709-3715.
7. Vousden KH. Human papillomavirus and cervical carcinoma: review. Cancer Cells. 1989;1:43-50.
8. Moy RL, Eliezri YD, Nuovo GJ, Zitelli JA, Bennett RG, Silverstein S. Human papillomavirus type 16 DNA in periungual squamous cell carcinomas. JAMA. 1989;261:2269-2273.
9. Palefsky JM, Holly EA, Gonzales J, Berline J, Ahn DK, Greenspan JS. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res. 1991;51:1014-1019.
10. Pierceall WE, Goldberg LH, Anantheswamy HN. Presence of HPV type 16 DNA sequences in human non-melanoma skin cancers. J Invest Dermatol. 1991;97:880-884.
11. Gupta AK, Cardella CJ, Haberman HF. Cutaneous malignant neoplasms in patients with renal transplants. Arch Dermatol. 1986;122:1288-1293.
12. Rudlinger R, Smith IW, Bunney MH, Hunter JA. Human papillomavirus infections in a group of renal transplant recipients. Br J Dermatol. 1986;115:681-692.
13. Euvrard S, Chardonnet Y, Hermier C, Viac J, Thivolet J. Verrues et carcinomes epidermoides apres transplantation renale. Ann Dermatol Venereol. 1989;116:201-211.
14. Johnson TM, Rowe DE, Nelson BR, Swanson NA. Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol. 1992;26:467-484.
15. Hoyo E, Kanitakis J, Euvrard S, Thivolet J. Proliferation characteristics of cutaneous squamous cell carcinomas developing in organ graft recipients. Arch Dermatol. 1993;129:324-327.
16. Stark LA, Arends MJ, McLaren KM, et al. Prevalence of human papillomavirus DNA in cutaneous neoplasms from renal allograft recipients supports a possible viral role in tumour promotion. Br J Cancer. 1994;69:222-229.
17. Shamanin V, Glover M, Rausch C, et al. Specific types of human papilloma-virus found in benign proliferations and carcinomas of the skin in immuno-suppressed patients. Cancer Res. 1994;54:4610-4613.
18. Moy R, Eliezri YD. Significance of HPV-induced squamous cell cancer to dermatologists. Arch Dermatol. 1994;130:235-238.
19. Van der Leest RJ, Zachow KR, Ostrow RS, Bender M, Pass F, Faras AJ. Human papillomavirus heterogeneity in 36 renal transplant recipients. Arch Dermatol. 1987;123:354-357.
20. Barr BBB, Benton EC, McLaren K, et al. Human papilloma virus infection and skin cancer in renal allograft recipients. Lancet. 1989;1:124-129.
21. Stark LA, Arends MJ, McLaren KM, et al. Accumulation of p53 is associated with tumour progression in cutaneous lesions of renal allograft recipients. Br J Cancer. 1994;70:662-667.
22. McGregor JM, Farthing A, Crook T, et al. Posttransplant skin cancer: a possible role for p53 gene mutation but not for oncogenic human papillomaviruses. J Am Acad Dermatol. 1994;30:701-706.
23. Crook T, Wrede D, Vousden KH. p53 Point mutation in HPV negative human cervical carcinoma cell lines. Oncogene. 1991;6:873-875.
24. Srivastava S, Tong YA, Devadas K, Zou ZQ, Chen Y, Pirollo KF, Chang EH. The status of the p53 gene in human papilloma virus positive or negative cervical carcinoma cell lines. Carcinogenesis. 1992;13:1273-1275.
25. Wrede D, Tidy JA, Crook T, Lane D, Vousden KH. Expression of RB and p53 proteins in HPV-positive and HPV-negative cervical carcinoma cell lines. Mol Carcinog. 1991;4:171-175.
26. McGregor JM, Yu CC-W, Dublin EA, Levison DA, MacDonald DM. Aberrant expression of p53 tumour-suppressor protein in non-melanoma skin cancer. Br J Dermatol. 1992;127:463-469.
27. Hall PA, McKee PH, Menage HD, Dover R, Lane DP. High levels of p53 protein in UV-irradiated normal human skin. Oncogene. 1993;8:203-207.
28. Kamb, A. Sun protection factor p53. Nature. 1994;372:730-731.
29. Kerschmann RL, McCalmont TH, LeBoit PE. p53 Oncoprotein expression and proliferation index in keratoacanthoma and squamous cell carcinoma. Arch Dermatol. 1994;130:181-186.
30. McNutt NS, Saenz-Santamaria C, Volkenandt M, Shea CR, Albino AP. Abnormalities of p53 protein expression in cutaneous disorders. Arch Dermatol. 1994;130:225-232.
31. Park DJ, Wilczynski SP, Paquette RL, Miller CW, Koeffler HP. p53 Mutations in HPV-negative cervical carcinoma. Oncogene. 1994;9:205-210.
32. Ziegler A, Jonason AS, Leffell DJ, et al. Sunburn and p53 in the onset of skin cancer. Nature. 1994;372:773-776.
33. Lever WF, Schaumburg-Lever G. Histopathology of the Skin. 7th ed. Philadelphia, Pa: JB Lippincott; 1990;549-555, 623-626.
34. van den Brute A, Snijders P, Gordun R, Bleker O, Meuer C, Walboomers J. General primer mediated PCR permits detection of sequenced and still unsequenced human papillomavirus genotypes in cervical scrapes and carcinomas. Int J Cancer. 1990;45:644-649.
35. Gregoire L, Arella M, Campione-Piccardo J, Lancaster WD. Amplification of human papillomavirus sequences using conserved primers. J Clin Microbiol. 1989;27:2660-2665.
36. Manos M, Ting Y, Wright D, Lewis A, Broker T, Wolinsky S. Use of polymerase chain reaction amplification for the detection of genital human papilloma-viruses. Cancer Cells. 1989;7:209-214.
37. Rady PL, Yen A, Rollefson JL, et al. Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet. 1995;345:1339-1340.
38. Gallagher RP, Hill GB, Bajdik CD, et al. Sunlight exposure, pigmentary factors, and risk of nonmelanocytic skin cancer. Arch Dermatol. 1995;131:157-163.
39. Penn I. Cancers complicating organ transplantation. N Engl J Med. 1990;323:1767-1769.
40. Bavinck JNB, Vermeer BJ, van der Woude FJ, et al. Relation between skin cancer and HLA antigens in renal-transplant recipients. N Engl J Med. 1991;325:843-848.
41. Streilein JW. Immunogenetic factors in skin cancer. N Engl J Med. 1991;325:884-887.
42. Kawashima M, Favre M, Obalek S, Jablonska S, Orth G. Premalignant lesions and cancers of the skin in the general population: evaluation of the role of human papillomaviruses. J Invest Dermatol. 1990;95:537-542.
43. Crum CP, Ikenberg H, Richart RM, Gissman L. Human papillomavirus type 16 and early cervical neoplasia. N Engl J Med. 1984;310:880-883.
44. Wright TC, Richart RM. Role of human papillomavirus in the pathogenesis of genital tract warts and cancer: review. Gynecol Oncol. 1990;37:151-164.
45. Lutzner M, Croissant O, Ducasse MF, Kreis H, Crosnier J, Orth G. A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol. 1980;75:353-356.
46. Rudlinger R, Grob R. Papillomavirus infection and skin cancer in renal allograft recipients. Lancet. 1989;1:1132-1133.
47. Rady P, Scinicariello F, Wagner RF Jr, Tyring SK. p53 Mutations in basal cell carcinomas. Cancer Res. 1992;52:3804-3806.
48. Gusterson BA, Anbazhagen R, Warren W, et al. Expression of p53 in premalignant and malignant squamous epithelium. Oncogene. 1991;6:1785-1789.
49. Scheffner M, Werness BA, Huibregtse UM, Levine AJ, Howley PM. The E6 oncoprotein encoded by HPV 16 and 18 promotes the degradation of p53. Cell. 1990;63:1129-1136.
50. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science. 1989;243:934-937.
51. Werness BA, Levine AJ, Howley PM. Association of human papillomavirus types 16 and 18 E6 proteins with p53. Science. 1990;248:76-79.
52. Vahakangus KH, Samet JM, Metcalf RA, et al. Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners. Lancet. 1992;339:576-580.
53. Bhargava V, Thor A, Deng G, et al. The association of p53 immunopositivity with tumor proliferation and other prognostic indicators in breast cancer. Mod Pathol. 1994;7:361-368.
54. Rady PL, Chin R, Arany I, Hughes TK, Tyring SK. Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses. J Virol Methods. 1993;43:335-350.
55. Winkelstein W Jr. Smoking and cervical cancer - current status: a review. Am J Epidemiol. 1990;131:945-960.